Navigation Links
BioHealth Innovation, Inc. Appoints Qiagen's Douglas Liu to Board of Directors
Date:4/30/2012

ROCKVILLE, Md., April 30, 2012 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the appointment of Douglas Liu, Senior Vice President of Global Operations at Qiagen, to its Board of Directors.

"Doug is an outstanding addition to our board," said Scott Carmer, BioHealth Innovation, Inc. Chairman of the Board and Executive Vice President of Commercial Operations at MedImmune. "His in-depth experience in strategic planning, operations and R&D in immunodiagnostics, molecular diagnostics, and other healthcare market sectors will prove invaluable as BHI drives biohealth commercialization opportunities in Central Maryland."

Mr. Liu currently serves as Senior Vice President of Global Operations for Qiagen, a German-based diagnostics company with a campus in Germantown, Maryland. He joined the company in 2005 after working at Bayer Healthcare as Head of Operations for Nucleic Acid Diagnostics in the U.S., and in Strategic Planning and Consulting at Bayer AG, Leverkusen. Mr. Liu has an M.B.A. from Boston University and a science degree from the University of Illinois. He also lived and worked in Germany for five years. Since returning to the U.S. in 2007, Mr. Liu has served on several local boards including the Governor's International Advisory Council & the board of MdBio/Tech Council of Maryland.

"I am honored to be part of an organization that has brought together key players in science, entrepreneurship and capital to change the dialogue about what we can be as a region," said Mr. Liu. "BHI's mission fits well with Qiagen's goal of advancing human health globally while contributing to the local economy and community."

Chairman Carmer expressed his appreciation for BHI's departing board member Dennis Fallen, who was with Rockville-based Fisher Biosciences and has accepted a position outside of the region. "Dennis served BHI well both as a work group member to help establish the organization and later as a board member," said Mr. Carmer. "We wish him the best in his new venture."

About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. Learn more at www.biohealthinnovation.org.


'/>"/>
SOURCE BioHealth Innovation, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Maryland Business, Academic and Biopharma Groups Underscore Commitment to Medical Innovation, Finding Cures and Supporting the Economy
2. Xconomy Launches XSITE 2009; First Annual Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University
3. Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving Recovery Through Discovery
4. Kendle Realigns C-Suite Leadership to Drive Increased Innovation, Productivity and Organizational Efficiency
5. New Jerseys Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development
6. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
7. Omeros Appoints David A. Mann to its Board of Directors
8. RainDance Technologies Appoints Olex Vice President, System Development
9. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
10. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
11. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... ... January 12, 2017 , ... Each year, Crain’s Detroit Business News ranks the ... evaluates the patent estate of a company, its impact and significance, and the likelihood ... the way in technologies that transform energy sources such as low dose X-ray and ...
(Date:1/12/2017)... ... January 12, 2017 , ... After ... Lisa Rosendahl’s doctors gave her only a few months to live. Now a ... that has stabilized Rosendahl’s disease and increased both the quantity and quality of ...
(Date:1/12/2017)... and Pune, India , January 12, 2017 ... Toxicity Testing Market by Type and End Users - Global Opportunity Analysis and Industry ... million by 2022 from $2,921 million in 2015, growing at a CAGR of 15.07% ... ... Allied Market Research Logo ...
(Date:1/11/2017)... Colo. (PRWEB) , ... January 11, 2017 , ... ... the journal Clinical Cancer Research show early promise of the investigational anti-cancer agent ... despite a median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated ...
Breaking Biology Technology:
(Date:1/6/2017)... -- Delta ID Inc., a leader in consumer-grade iris scanning ... CES® 2017. Delta ID has collaborated with Gentex Corporation ... of iris scanning as a secure, reliable and convenient ... car, and as a way to elevate the security ... ID and Gentex will demonstrate (booth #7326 LVCC) a ...
(Date:1/3/2017)... LAS VEGAS , Jan. 3, 2017 ... announced the introduction of Onitor Track, an innovative biometric ... and men, showcasing this month at the 2017 Consumer ... . In the U.S., the World ... affect more than two-thirds of adults who are overweight ...
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
Breaking Biology News(10 mins):